Wednesday, November 18, 2026

FDA Quality Management System Regulation (QMSR) Transition: Harmonizing 21 CFR Part 820 with ISO 13485:2016

Global medical device manufacturers face critical deadlines as the FDA replaces legacy Good Manufacturing Practices (CGMP) with the modernized QMSR framework, aligning inspection criteria with ISO 13485.

NewsKrez Editorial DeskNovember 17, 2026 • 4:29 AM UTC
6 min read0 views
FDA Quality Management System Regulation (QMSR) Transition: Harmonizing 21 CFR Part 820 with ISO 13485:2016
Quality management system documentation and regulatory inspection compliance audit.

The United States FDA's final rule amending the medical device Quality System regulation (21 CFR Part 820) represents the most significant overhaul of device quality regulations in over three decades. Designated as the Quality Management System Regulation (QMSR), the rule harmonizes US requirements with the international standard ISO 13485:2016.

Key Operational Adjustments for Device Manufacturers

Quality and regulatory affairs leadership must adapt standard operating procedures across five core domains:

  1. Risk Management Across the Product Lifecycle: Direct incorporation of ISO 14971 risk management principles into design controls, supplier evaluations, and post-market vigilance.
  2. Clarified Terminology: Shifting from legacy terms such as 'DMR' (Device Master Record) and 'DHR' (Device History Record) to ISO standard documentation architectures.
  3. Supply Chain and Outsourced Process Controls: Rigorous vendor qualification requirements with documented traceability.
  4. Computer Software Assurance (CSA): Transitioning from cumbersome traditional CSV methodologies to risk-based, automated CSA testing.
Regulatory Verification & Source Attribution

This intelligence report was compiled and verified by the NewsKrez Editorial & Regulatory Intelligence Desk.

Sponsored Intelligence
Medical Device Software Compliance

Automated 21 CFR Part 820 & ISO 13485 Verification

Explore Solution →